26 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday.
HC Wainwright & Co. Maintains Buy on Aptinyx, Lowers Price Target to $2
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Aptinyx (NASDAQ:APTX) with a Buy and lowers the price target from $8 to $2.
Cantor Fitzgerald Maintains Overweight on Aptinyx, Lowers Price Target to $5
Cantor Fitzgerald analyst Charles Duncan maintains Aptinyx (NASDAQ:APTX) with a Overweight and lowers the price target from $11 to $5.
53 Biggest Movers From Yesterday
Gainers
MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.
Mid-Afternoon Market Update: S&P 500 Turns Positive; Aptinyx Shares Slide
U.S. stocks pared losses, with the Dow Jones and S&P 500 turning positive toward the end of trading on Thursday.
Mid-Day Market Update: Dow Tumbles Over 200 Points; Momentus Shares Jump
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Thursday.
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers
IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their outstanding shares is at $41.9 million.
Mid-Morning Market Update: Markets Mixed; US Jobless Claims Fall Last Week
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 150 points on Thursday.
Aptinyx Shares Tank On Disappointed Data From Mid-Stage Diabetic Peripheral Neuropathy Study
Aptinyx Inc (NASDAQ: APTX) shares are plunging after results from a Phase 2b study of NYX-2925 in patients with painful diabetic peripheral neuropathy (DPN).